In conclusion, our study unravels a novel role of MEK1/2, HDACs, and SNAI2 in orchestrating survival of a specific class of cancers, driving the expression of two well-known mediators of apoptosis in aggressive cancers, BIM and BMF. Here, BCL2L11 is linked to cancer.